Multimorbidity may up seniors’ dementia risk by 63 percent over 15 years
By
Alicia Lasek
Oct 03, 2022
Identifying high-risk disease clusters could help clinicians to better target patients for dementia care, researchers say.
Enrichment activities activate genes that help seniors resist cognitive decline
By
Amy Novotney
Nov 08, 2021
Spending time on intellectually stimulating activities appears to activate a gene family known as MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline. That’s...
Precision aging: Researchers propose a new approach to keep brains healthy, longer
By
Alicia Lasek
Jun 18, 2019
With life spans increasing, it may be time to discard a one-size-fits-all approach to brain health. A group of researchers propose a new precision medicine model.
Cognitive differences between young and old shrink with time, research suggests
By
Donna Shryer
May 06, 2024
Three review studies examined how cognitive abilities change as people age, particularly focusing on whether there are differences between older and younger adults and how these differences evolve over...
The coronavirus likely began to spread worldwide last year, say researchers
By
Alicia Lasek
May 06, 2020
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
Certain female carriers of Alzheimer’s gene have faster decline than males: study
By
Alicia Lasek
Nov 22, 2022
Women who carry the APOE e4 gene and develop early-onset Alzheimer’s disease may have quicker cognitive decline than men with these attributes, a new study has found.
Vitamin D may protect against Alzheimer’s, new report asserts
By
Alicia Lasek
Mar 06, 2023
Exposure to vitamin D supplements is linked to longer dementia-free survival and a lower rate of dementia when compared to no exposure, a new study has found.
Monoclonal antibodies cut COVID-19 hospitalizations in high-risk adults: Mayo Clinic
By
Alicia Lasek
Jul 22, 2021
Patients treated early in the disease with either one of two antibody therapies had similarly low rates of hospitalization within 28 days.
FDA approves first generic of glucagon to treat severe low blood sugar
By
Alicia Lasek
Jan 04, 2021
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
New hearing guidelines aim to expand detection while promoting treatment, access
By
Kristen Fischer
May 02, 2024
The American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) this week published updated guidelines on age-related hearing loss. Among the guidelines: Everyone 50 and up should...